Javelot H, Meyer G, Becker G, Post G, Runge V, Pospieszynski P, Schneiderlin T, Armand-Branger S, Michel B, Weiner L, Faria CGF, Drapier D, Fakra E, Fossati P, Haffen E, Yrondi A, Hingray C

Encephale. 2021 Dec 4;:

Blood-Brain Barrier Permeability: Is 5-Hydroxytryptamine Receptor Type 4 a Game Changer?

Becker G, Da Silva S, Sabo AN, Antal MC, Kemmel V, Monassier L

Pharmaceutics. 2021 11 3;13(11):

Angiotensin-converting enzyme inhibitor induced angioedema: not always a class effect? A case report and short narrative review.

Becker G, Rougerie F, Sabo AN, Dalmas MC, Ayme-Dietrich E, Monassier L

Curr Med Res Opin. 2021 11;37(11):1855-1858

Characterization of the spontaneous degenerative mitral valve disease in FVB mice.

Ayme-Dietrich E, Da Silva S, Bouabout GA, Arnoux A, Guyonnet J, Becker G, Monassier L

PLoS One. 2021 09 2;16(9):e0257022

Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology.

Sabo AN, Jannier S, Becker G, Lessinger JM, Entz-Werlé N, Kemmel V

Pharmaceutics. 2021 Mar 30;13(4):

Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.

Muller M, Lefebvre F, Harlay ML, Glady L, Becker G, Muller C, Aberkane O, Tawk M, Julians M, Romoli A, Hecketsweiler S, Schneider F, Pottecher J, Chamaraux-Tran TN

Trials. 2021 Feb 11;22(1):131

Impact of the COVID-19 pandemic on clinical research in hospitals: observational study in the first epicenter of the epidemic during the general lockdown in France.

Becker G, Martin T, Sabo AN, Bertrand F, Hutt A, Ayme-Dietrich E, Michel B, Monassier L, Gourieux B

Eur Rev Med Pharmacol Sci. 2021 01;25(2):1158-1162

A UV-Raman spectrometry method for quality control of anticancer preparations: Results after 18 months of implementation in hospital pharmacy.

Nardella F, Beck M, Collart-Dutilleul P, Becker G, Boulanger C, Perello L, Gairard-Dory A, Gourieux B, Ubeaud-Séquier G

Int J Pharm. 2016 Feb 29;499(1-2):343-350

[Mecanisms of pharmacokinetic interactions involving oral anticancer agents].

Levêque D, Duval C, Poulat C, Palas B, El Aatmani A, Dory A, Becker G, Gourieux B

Bull Cancer. 2015 01;102(1):65-72

Fiche personne Publications

Retrouvez aussi

Personnes

Equipes

Plateformes

Unités de recherche, établissements

Projets de recherche

Publications scientifiques

Dr BECKER Guillaume

Fiche personne

Coordonnées

Territoire

Statut

Affiliation

Équipes/plateformes

Recherche

Publications

The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials.

The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials.

Flavoured and nicotine-containing e-liquids impair homeostatic properties of an alveolar-capillary cell model.

A Narrative Review on Axonal Neuroprotection in Multiple Sclerosis.

[Anticholinergic scales: Use in psychiatry and update of the anticholinergic impregnation scale].

Blood-Brain Barrier Permeability: Is 5-Hydroxytryptamine Receptor Type 4 a Game Changer?

Angiotensin-converting enzyme inhibitor induced angioedema: not always a class effect? A case report and short narrative review.

Characterization of the spontaneous degenerative mitral valve disease in FVB mice.

Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology.

Impact of intravenous lidocaine on clinical outcomes of patients with ARDS during COVID-19 pandemia (LidoCovid): A structured summary of a study protocol for a randomised controlled trial.

Impact of the COVID-19 pandemic on clinical research in hospitals: observational study in the first epicenter of the epidemic during the general lockdown in France.

COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?

Clinical Pharmacokinetics and Pharmacodynamics of Dasatinib.

The role of therapeutic drug monitoring in the management of safety of anticancer agents: a focus on 3 cytotoxics.

Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach.

[Generic drugs controversy in oncology].

A UV-Raman spectrometry method for quality control of anticancer preparations: Results after 18 months of implementation in hospital pharmacy.

[Mecanisms of pharmacokinetic interactions involving oral anticancer agents].

Retrouvez aussi